Host response profile of human brain proteome in toxoplasma encephalitis co-infected with HIV

Apeksha Sahu, Satwant Kumar, Sreelakshmi K. Sreenivasamurthy, Lakshmi Dhevi N. Selvan, Anil K. Madugundu, Soujanya D. Yelamanchi, Vinuth N. Puttamallesh, Gourav Dey, Abhijith K. Anil, Anand Srinivasan, Kanchan K. Mukherjee, Harsha Gowda, Parthasarathy Satishchandra, Anita Mahadevan, Akhilesh Pandey, Thottethodi Subrahmanya Keshava Prasad, Susarla Krishna Shankar

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Toxoplasma encephalitis is caused by the opportunistic protozoan parasite Toxoplasma gondii. Primary infection with T. gondii in immunocompetent individuals remains largely asymptomatic. In contrast, in immunocompromised individuals, reactivation of the parasite results in severe complications and mortality. Molecular changes at the protein level in the host central nervous system and proteins associated with pathogenesis of toxoplasma encephalitis are largely unexplored. We used a global quantitative proteomic strategy to identify differentially regulated proteins and affected molecular networks in the human host during T. gondii infection with HIV co-infection. Results: We identified 3,496 proteins out of which 607 proteins were differentially expressed (≥1.5-fold) when frontal lobe of the brain from patients diagnosed with toxoplasma encephalitis was compared to control brain tissues. We validated differential expression of 3 proteins through immunohistochemistry, which was confirmed to be consistent with mass spectrometry analysis. Pathway analysis of differentially expressed proteins indicated deregulation of several pathways involved in antigen processing, immune response, neuronal growth, neurotransmitter transport and energy metabolism. Conclusions: Global quantitative proteomic approach adopted in this study generated a comparative proteome profile of brain tissues from toxoplasma encephalitis patients co-infected with HIV. Differentially expressed proteins include previously reported and several new proteins in the context of T. gondii and HIV infection, which can be further investigated. Molecular pathways identified to be associated with the disease should enhance our understanding of pathogenesis in toxoplasma encephalitis.

Original languageEnglish (US)
JournalClinical Proteomics
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Toxoplasma
Encephalitis
Proteome
Brain
HIV
Proteins
Toxoplasmosis
Proteomics
HIV Infections
Parasites
Tissue
Deregulation
Antigen Presentation
Neurology
Frontal Lobe
Coinfection
Energy Metabolism
Mass spectrometry
Neurotransmitter Agents
Mass Spectrometry

Keywords

  • Chronic meningitis
  • Immunosuppression
  • iTRAQ labeling
  • LTQ-Orbitrap Velos
  • Neuroinfections
  • Opportunistic infections

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Sahu, A., Kumar, S., Sreenivasamurthy, S. K., Selvan, L. D. N., Madugundu, A. K., Yelamanchi, S. D., ... Shankar, S. K. (2014). Host response profile of human brain proteome in toxoplasma encephalitis co-infected with HIV. Clinical Proteomics, 11(1). https://doi.org/10.1186/1559-0275-11-39

Host response profile of human brain proteome in toxoplasma encephalitis co-infected with HIV. / Sahu, Apeksha; Kumar, Satwant; Sreenivasamurthy, Sreelakshmi K.; Selvan, Lakshmi Dhevi N.; Madugundu, Anil K.; Yelamanchi, Soujanya D.; Puttamallesh, Vinuth N.; Dey, Gourav; Anil, Abhijith K.; Srinivasan, Anand; Mukherjee, Kanchan K.; Gowda, Harsha; Satishchandra, Parthasarathy; Mahadevan, Anita; Pandey, Akhilesh; Prasad, Thottethodi Subrahmanya Keshava; Shankar, Susarla Krishna.

In: Clinical Proteomics, Vol. 11, No. 1, 01.01.2014.

Research output: Contribution to journalArticle

Sahu, A, Kumar, S, Sreenivasamurthy, SK, Selvan, LDN, Madugundu, AK, Yelamanchi, SD, Puttamallesh, VN, Dey, G, Anil, AK, Srinivasan, A, Mukherjee, KK, Gowda, H, Satishchandra, P, Mahadevan, A, Pandey, A, Prasad, TSK & Shankar, SK 2014, 'Host response profile of human brain proteome in toxoplasma encephalitis co-infected with HIV', Clinical Proteomics, vol. 11, no. 1. https://doi.org/10.1186/1559-0275-11-39
Sahu A, Kumar S, Sreenivasamurthy SK, Selvan LDN, Madugundu AK, Yelamanchi SD et al. Host response profile of human brain proteome in toxoplasma encephalitis co-infected with HIV. Clinical Proteomics. 2014 Jan 1;11(1). https://doi.org/10.1186/1559-0275-11-39
Sahu, Apeksha ; Kumar, Satwant ; Sreenivasamurthy, Sreelakshmi K. ; Selvan, Lakshmi Dhevi N. ; Madugundu, Anil K. ; Yelamanchi, Soujanya D. ; Puttamallesh, Vinuth N. ; Dey, Gourav ; Anil, Abhijith K. ; Srinivasan, Anand ; Mukherjee, Kanchan K. ; Gowda, Harsha ; Satishchandra, Parthasarathy ; Mahadevan, Anita ; Pandey, Akhilesh ; Prasad, Thottethodi Subrahmanya Keshava ; Shankar, Susarla Krishna. / Host response profile of human brain proteome in toxoplasma encephalitis co-infected with HIV. In: Clinical Proteomics. 2014 ; Vol. 11, No. 1.
@article{7fb010e2e08241479f9a9326661ecc6e,
title = "Host response profile of human brain proteome in toxoplasma encephalitis co-infected with HIV",
abstract = "Background: Toxoplasma encephalitis is caused by the opportunistic protozoan parasite Toxoplasma gondii. Primary infection with T. gondii in immunocompetent individuals remains largely asymptomatic. In contrast, in immunocompromised individuals, reactivation of the parasite results in severe complications and mortality. Molecular changes at the protein level in the host central nervous system and proteins associated with pathogenesis of toxoplasma encephalitis are largely unexplored. We used a global quantitative proteomic strategy to identify differentially regulated proteins and affected molecular networks in the human host during T. gondii infection with HIV co-infection. Results: We identified 3,496 proteins out of which 607 proteins were differentially expressed (≥1.5-fold) when frontal lobe of the brain from patients diagnosed with toxoplasma encephalitis was compared to control brain tissues. We validated differential expression of 3 proteins through immunohistochemistry, which was confirmed to be consistent with mass spectrometry analysis. Pathway analysis of differentially expressed proteins indicated deregulation of several pathways involved in antigen processing, immune response, neuronal growth, neurotransmitter transport and energy metabolism. Conclusions: Global quantitative proteomic approach adopted in this study generated a comparative proteome profile of brain tissues from toxoplasma encephalitis patients co-infected with HIV. Differentially expressed proteins include previously reported and several new proteins in the context of T. gondii and HIV infection, which can be further investigated. Molecular pathways identified to be associated with the disease should enhance our understanding of pathogenesis in toxoplasma encephalitis.",
keywords = "Chronic meningitis, Immunosuppression, iTRAQ labeling, LTQ-Orbitrap Velos, Neuroinfections, Opportunistic infections",
author = "Apeksha Sahu and Satwant Kumar and Sreenivasamurthy, {Sreelakshmi K.} and Selvan, {Lakshmi Dhevi N.} and Madugundu, {Anil K.} and Yelamanchi, {Soujanya D.} and Puttamallesh, {Vinuth N.} and Gourav Dey and Anil, {Abhijith K.} and Anand Srinivasan and Mukherjee, {Kanchan K.} and Harsha Gowda and Parthasarathy Satishchandra and Anita Mahadevan and Akhilesh Pandey and Prasad, {Thottethodi Subrahmanya Keshava} and Shankar, {Susarla Krishna}",
year = "2014",
month = "1",
day = "1",
doi = "10.1186/1559-0275-11-39",
language = "English (US)",
volume = "11",
journal = "Clinical Proteomics",
issn = "1542-6416",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Host response profile of human brain proteome in toxoplasma encephalitis co-infected with HIV

AU - Sahu, Apeksha

AU - Kumar, Satwant

AU - Sreenivasamurthy, Sreelakshmi K.

AU - Selvan, Lakshmi Dhevi N.

AU - Madugundu, Anil K.

AU - Yelamanchi, Soujanya D.

AU - Puttamallesh, Vinuth N.

AU - Dey, Gourav

AU - Anil, Abhijith K.

AU - Srinivasan, Anand

AU - Mukherjee, Kanchan K.

AU - Gowda, Harsha

AU - Satishchandra, Parthasarathy

AU - Mahadevan, Anita

AU - Pandey, Akhilesh

AU - Prasad, Thottethodi Subrahmanya Keshava

AU - Shankar, Susarla Krishna

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background: Toxoplasma encephalitis is caused by the opportunistic protozoan parasite Toxoplasma gondii. Primary infection with T. gondii in immunocompetent individuals remains largely asymptomatic. In contrast, in immunocompromised individuals, reactivation of the parasite results in severe complications and mortality. Molecular changes at the protein level in the host central nervous system and proteins associated with pathogenesis of toxoplasma encephalitis are largely unexplored. We used a global quantitative proteomic strategy to identify differentially regulated proteins and affected molecular networks in the human host during T. gondii infection with HIV co-infection. Results: We identified 3,496 proteins out of which 607 proteins were differentially expressed (≥1.5-fold) when frontal lobe of the brain from patients diagnosed with toxoplasma encephalitis was compared to control brain tissues. We validated differential expression of 3 proteins through immunohistochemistry, which was confirmed to be consistent with mass spectrometry analysis. Pathway analysis of differentially expressed proteins indicated deregulation of several pathways involved in antigen processing, immune response, neuronal growth, neurotransmitter transport and energy metabolism. Conclusions: Global quantitative proteomic approach adopted in this study generated a comparative proteome profile of brain tissues from toxoplasma encephalitis patients co-infected with HIV. Differentially expressed proteins include previously reported and several new proteins in the context of T. gondii and HIV infection, which can be further investigated. Molecular pathways identified to be associated with the disease should enhance our understanding of pathogenesis in toxoplasma encephalitis.

AB - Background: Toxoplasma encephalitis is caused by the opportunistic protozoan parasite Toxoplasma gondii. Primary infection with T. gondii in immunocompetent individuals remains largely asymptomatic. In contrast, in immunocompromised individuals, reactivation of the parasite results in severe complications and mortality. Molecular changes at the protein level in the host central nervous system and proteins associated with pathogenesis of toxoplasma encephalitis are largely unexplored. We used a global quantitative proteomic strategy to identify differentially regulated proteins and affected molecular networks in the human host during T. gondii infection with HIV co-infection. Results: We identified 3,496 proteins out of which 607 proteins were differentially expressed (≥1.5-fold) when frontal lobe of the brain from patients diagnosed with toxoplasma encephalitis was compared to control brain tissues. We validated differential expression of 3 proteins through immunohistochemistry, which was confirmed to be consistent with mass spectrometry analysis. Pathway analysis of differentially expressed proteins indicated deregulation of several pathways involved in antigen processing, immune response, neuronal growth, neurotransmitter transport and energy metabolism. Conclusions: Global quantitative proteomic approach adopted in this study generated a comparative proteome profile of brain tissues from toxoplasma encephalitis patients co-infected with HIV. Differentially expressed proteins include previously reported and several new proteins in the context of T. gondii and HIV infection, which can be further investigated. Molecular pathways identified to be associated with the disease should enhance our understanding of pathogenesis in toxoplasma encephalitis.

KW - Chronic meningitis

KW - Immunosuppression

KW - iTRAQ labeling

KW - LTQ-Orbitrap Velos

KW - Neuroinfections

KW - Opportunistic infections

UR - http://www.scopus.com/inward/record.url?scp=84912552058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912552058&partnerID=8YFLogxK

U2 - 10.1186/1559-0275-11-39

DO - 10.1186/1559-0275-11-39

M3 - Article

AN - SCOPUS:84912552058

VL - 11

JO - Clinical Proteomics

JF - Clinical Proteomics

SN - 1542-6416

IS - 1

ER -